TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PHAT

Phathom Pharmaceuticals Inc

Healthcare · Biotechnology

7.50$ -0.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement PHAT
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+8,001.5% +216.9%
+3,650.0% +73.7% +19.0% -73.1% +4,674.3% +183.4%
+9,080.4% +222.6%
+496,255.0% -1.1% -26.3% -1.2% -30.2% -31.7% -3.8%
+476.3% +296.3% +128.0% +61.0% +16.8% +146.5% -3.8%
+8,570.6% +18.0% +7.3% +27.7% -2.3% +93.5% -3.8%
+32,030.8% +9.7% +48.2% +302.3% +53.7% +71.6% -5.4%
-349,230.8% -0.9% +500.4% +65.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?